Chemokines, including CCR2 and CCR5 ligands, have been demonstrated to have pronociceptive properties, and their levels are increased in CCI and STZ models of neuropathic pain [48,49,50,51,52,53,54]. Here, CCR5 is linked to neuropathic pain.